PlainRecalls
FDA Devices Moderate Class II Ongoing

THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA

Reported: February 16, 2022 Initiated: December 10, 2021 #Z-0567-2022

Product Description

THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA

Reason for Recall

This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.

Details

Units Affected
3
Distribution
US Nationwide distribution in the states of CA, FL, GA, MA, MI, NC, NJ, NY, OH, TN, TX, VA, WV.
Location
Dublin 15, N/A

Frequently Asked Questions

What product was recalled?
THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA. Recalled by Mallinckrodt Pharmaceuticals Ireland Ltd. Units affected: 3.
Why was this product recalled?
This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 16, 2022. Severity: Moderate. Recall number: Z-0567-2022.